RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+5.37%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$2.38B
AUM Growth
+$2.38B
(+1.8%)
Cap. Flow
-$42.6M
Cap. Flow
% of AUM
-1.79%
Top 10 Holdings %
Top 10 Hldgs %
48.22%
Holding
72
New
8
Increased
21
Reduced
14
Closed
10
Top Buys
| 1 |
Roivant Sciences
ROIV
|
$81.3M |
| 2 |
NRG Energy
NRG
|
$24.3M |
| 3 |
QuidelOrtho
QDEL
|
$21.7M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$18.4M |
| 5 |
Heron Therapeutics
HRTX
|
$15.4M |
Top Sells
| 1 |
Vistra
VST
|
$73.4M |
| 2 |
LendingClub
LC
|
$51.8M |
| 3 |
Scorpio Tankers
STNG
|
$48.8M |
| 4 |
Fluor
FLR
|
$38M |
| 5 |
Par Pacific Holdings
PARR
|
$25.9M |
Sector Composition
| 1 | Healthcare | 39.91% |
| 2 | Energy | 13.82% |
| 3 | Industrials | 11.46% |
| 4 | Financials | 8.86% |
| 5 | Utilities | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLYA
26
DELISTED
Playa Hotels & Resorts
PLYA
| $37.6M | 1.41% |
5,195,629
-2,012,667
| -28% | -$14.6M |
|
27
Constellium
CSTM
$1.93B
| $35.6M | 1.33% |
1,954,274
-270,380
| -12% | -$4.92M |
|
28
Magnite
MGNI
$3.49B
| $30.2M | 1.13% |
4,000,000
+1,785,978
| +81% | +$13.5M |
|
|
29
Heron Therapeutics
HRTX
$204M
| $27.5M | 1.03% |
26,713,503
+14,963,503
| +127% | +$15.4M |
|
30
Arcutis Biotherapeutics
ARQT
$1.91B
| $26.7M | 1% |
5,034,530
+150,000
| +3% | +$797K |
|
|
31
QuidelOrtho
QDEL
$1.87B
| $21.7M | 0.81% |
+296,426
| New | +$21.7M |
|
32
Ovid Therapeutics
OVID
$94.6M
| $20.9M | 0.78% |
5,445,910
| – | – |
|
|
33
Vistra
VST
$63.7B
| $20M | 0.75% |
602,189
-2,211,032
| -79% | -$73.4M |
|
34
scPharmaceuticals
SCPH
$296M
| $19.3M | 0.72% |
2,713,287
+1,901,770
| +234% | +$13.5M |
|
|
RVNC
35
DELISTED
Revance Therapeutics, Inc.
RVNC
| $18.4M | 0.69% |
+1,600,000
| New | +$18.4M |
|
36
AdaptHealth
AHCO
$1.23B
| $17.8M | 0.67% |
1,961,199
-917,940
| -32% | -$8.35M |
|
37
Amneal Pharmaceuticals
AMRX
$3B
| $17M | 0.64% |
4,024,500
+1,423,121
| +55% | +$6.01M |
|
38
Zymeworks
ZYME
$1.07B
| $16.8M | 0.63% |
2,651,394
+293,817
| +12% | +$1.86M |
|
|
MREO
39
Mereo BioPharma
MREO
$275M
| $15M | 0.56% |
11,616,120
| – | – |
|
40
OmniAb
OABI
$219M
| $14.8M | 0.55% |
2,850,588
+2,148,535
| +306% | +$11.2M |
|
41
Madison Square Garden
MSGS
$4.71B
| $14.7M | 0.55% |
+83,512
| New | +$14.7M |
|
42
Pacira BioSciences
PCRX
$1.22B
| $14.1M | 0.53% |
+459,637
| New | +$14.1M |
|
43
Telesat
TSAT
$307M
| $13.7M | 0.51% |
959,764
-307,301
| -24% | -$4.39M |
|
44
Stratasys
SSYS
$863M
| $12.4M | 0.46% |
+910,633
| New | +$12.4M |
|
45
Trevi Therapeutics
TRVI
$871M
| $12.4M | 0.46% |
5,684,420
| – | – |
|
46
Sutro Biopharma
STRO
$85.6M
| $11.6M | 0.44% |
3,344,810
-703,934
| -17% | -$2.44M |
|
47
Clear Channel Outdoor Holdings
CCO
$636M
| $10.6M | 0.4% |
6,705,943
-10,685,484
| -61% | -$16.9M |
|
48
FTAI Infrastructure
FIP
$479M
| $10.3M | 0.39% |
3,193,530
| – | – |
|
49
Ardelyx
ARDX
$1.57B
| $10.2M | 0.38% |
+2,500,000
| New | +$10.2M |
|
50
Magnachip Semiconductor
MX
$107M
| $8.04M | 0.3% |
967,867
| – | – |
|